Search Results Search Sort by RelevanceMost Recent Original Research May 2021 Are Financial Incentives Appropriate Means of Encouraging Medication Adherence Among People Living With HIV? Toorjo Ghose, PhD, Virginia Shubert, JD, Sambuddha Chaudhuri, MBBS, PhD, Vaty Poitevien, MD, and Alison Updyke, PhD Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care. AMA J Ethics. 2021;23(5):E394-401. doi: 10.1001/amajethics.2021.394. Case and Commentary Aug 2019 How Should Physicians Steward Limited Resources While Ensuring That Patients Can Access Needed Medicines? Pete Croughan and Rebekah E. Gee, MD, MPH Louisiana has a subscription model for hepatitis C treatment, but costly medications challenge states’ capacities to cover patients. AMA J Ethics. 2019;21(8):E630-635. doi: 10.1001/amajethics.2019.630. Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167. Case and Commentary Feb 2020 When Is a Suboptimal Approach to Cancer Screening Better Than None? Ramy Sedhom, MD and Bishal Gyawali, MD, PhD Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach. AMA J Ethics. 2020;22(2):E93-101. doi: 10.1001/amajethics.2020.93. Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518. Original Research Jun 2022 لماذا نحتاج إلى رقابة أكثر صرامة على البحوث التي تشمل الأشخاصالمتأثرين بالصراع Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS AMA J Ethics. 2022;E518-529. doi: 10.1001/amajethics.2022.518. Case and Commentary Feb 2008 Correctional Mental Health Jeffrey L. Metzner, MD Virtual Mentor. 2008;10(2):92-95. doi: 10.1001/virtualmentor.2008.10.2.ccas3-0802. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Original Research May 2021 Are Financial Incentives Appropriate Means of Encouraging Medication Adherence Among People Living With HIV? Toorjo Ghose, PhD, Virginia Shubert, JD, Sambuddha Chaudhuri, MBBS, PhD, Vaty Poitevien, MD, and Alison Updyke, PhD Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care. AMA J Ethics. 2021;23(5):E394-401. doi: 10.1001/amajethics.2021.394.
Case and Commentary Aug 2019 How Should Physicians Steward Limited Resources While Ensuring That Patients Can Access Needed Medicines? Pete Croughan and Rebekah E. Gee, MD, MPH Louisiana has a subscription model for hepatitis C treatment, but costly medications challenge states’ capacities to cover patients. AMA J Ethics. 2019;21(8):E630-635. doi: 10.1001/amajethics.2019.630.
Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167.
Case and Commentary Feb 2020 When Is a Suboptimal Approach to Cancer Screening Better Than None? Ramy Sedhom, MD and Bishal Gyawali, MD, PhD Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach. AMA J Ethics. 2020;22(2):E93-101. doi: 10.1001/amajethics.2020.93.
Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518.
Original Research Jun 2022 لماذا نحتاج إلى رقابة أكثر صرامة على البحوث التي تشمل الأشخاصالمتأثرين بالصراع Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS AMA J Ethics. 2022;E518-529. doi: 10.1001/amajethics.2022.518.
Case and Commentary Feb 2008 Correctional Mental Health Jeffrey L. Metzner, MD Virtual Mentor. 2008;10(2):92-95. doi: 10.1001/virtualmentor.2008.10.2.ccas3-0802.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.